IFP Advisors’s Genomic Health, Inc. GHDX Stock Holding History

IFP Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-493	Closed	-$33K	–	3284
2019 Q3	$33K	Buy	+493	New	+$33.9K	﹤0.01%	1560
2019 Q1	–	Sell	-9	Closed	-$1K	–	3818
2018 Q4	$1K	Hold	9	–	–	﹤0.01%	3466
2018 Q3	$1K	Hold	9	–	–	﹤0.01%	3773
2018 Q2	$0	Sell	9 -148	-94%	-$5.87K	﹤0.01%	4169
2018 Q1	$5K	Hold	157	–	–	﹤0.01%	3216
2017 Q4	$5K	Buy	157 +78	+99%	+$2.49K	﹤0.01%	3265
2017 Q3	$3K	Buy	79 +70	+778%	+$2.21K	﹤0.01%	3682
2017 Q2	$0	Buy	+9	New	+$285	﹤0.01%	4308

IFP Advisors's GHDX Position: Q4 2019 in Review

IFP Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 493 shares — an estimated $33K sold.

IFP Advisors first reported a position in GHDX in Q2 2017 and held it in 8 quarters. The position peaked at $33K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

IFP Advisors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
IFP Advisors sold 493 Genomic Health, Inc. shares in Q4 2019, an estimated $33K.
IFP Advisors first reported a position in Genomic Health, Inc. in Q2 2017 and held it in 8 quarters.
IFP Advisors's Genomic Health, Inc. position peaked at $33K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on IFP Advisors's 13F filing for Q4 2019, filed 17 Jan 2020.